Literature DB >> 19690942

CGRP in migraine.

Peer Tfelt-Hansen, Messoud Ashina.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690942      PMCID: PMC3452099          DOI: 10.1007/s10194-009-0139-x

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


× No keyword cloud information.
Dear Editor, Concentrations of substances in plasma, in this case CGRP, can be presented in several different to ways, such as pmol/l [1-7], pg/ml [8, 9] and just recently as ng/ml [10]. These different concentrations can be compared when one uses the molecular weight of 3,790 for CGRP but it takes 5–10 min of arithmetic to do that. When you normally read a paper you do not stop and do the arithmetic needed in order to check the concentrations. In a recent paper in Journal of Headache and Pain, the plasma concentration of CGRP in cubital blood is given as 1.03 ng/ml in migraine [10]. This looks apparently reliable, but when the concentration in pmol/l, the standard way of presenting CGRP concentrations [1-7], is calculated the resulting concentration is 272 pmol/l. This was in migraine patients in the cubital vein outside attacks [10] and the CGRP levels are higher than any CGRP levels reported before both in external jugular blood [1-5], and cubital blood [6-9]. The authors state that the analyses were done with a commercially available ELISA kit and that the kit had a good sensitivity (range 0–25 ng/ml), but the detection limit for CGRP is not stated. The best way to avoid such problems is to present CGRP levels in pmol/l. One can then easily skim the literature and compare results in different studies.
  2 in total

1.  Insulin sensitizes neural and vascular TRPV1 receptors in the trigeminovascular system.

Authors:  Judit Rosta; Máté Tóth; Nadine Friedrich; Péter Sántha; Gábor Jancsó; Mária Dux
Journal:  J Headache Pain       Date:  2022-01-15       Impact factor: 7.277

2.  CGRP measurements in human plasma - a methodological study.

Authors:  Karl Messlinger; Birgit Vogler; Annette Kuhn; Julika Sertel-Nakajima; Florian Frank; Gregor Broessner
Journal:  Cephalalgia       Date:  2021-07-16       Impact factor: 6.292

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.